LAKE
FOREST, Calif., Nov. 7, 2023
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, today announced that it will release third quarter
2023 financial and operating results on Thursday, November 9, 2023, after the close of
the U.S. financial markets and will host a conference call and
webcast that day at 4:30 p.m. ET / 1:30
p.m. PT to discuss the results and corporate
developments.
To access the live call, dial 866-682-6100 (U.S.) or +1
862-298-0702 (International) and ask to join the BIOLASE call.
A live and archived webcast of the conference call will be
accessible on the BIOLASE Investor Relations Page. In
addition, a phone replay will be available approximately two hours
following the end of the call, and it will remain available for one
week. To access the call replay, dial 877-481-4010 or +1
919-882-2331 (International) and enter replay passcode 49456.
About BIOLASE
BIOLASE is a medical device company that
develops, manufactures, markets, and sells laser systems in
dentistry and medicine. BIOLASE's products advance the practice of
dentistry and medicine for patients and healthcare professionals.
As of December 31, 2022, BIOLASE's
proprietary laser products incorporate approximately 259 active
patents and 24 patent-pending technologies designed to provide
biologically and clinically superior performance with less pain and
faster recovery times. BIOLASE's innovative products provide
cutting-edge technology at competitive prices to deliver superior
results for dentists and patients. BIOLASE's principal
products are dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. From 1998 through December
31, 2022, BIOLASE has sold over 45,500 laser
systems in over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other
adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®,
Waterlase Express™, and laser dentistry,
find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram at
www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase
iPlus® are registered trademarks of BIOLASE,
Inc.
Contacts:
EVC Group, Inc.
Michael Polyviou/Todd Kehrli
(732) 232-6914
mpolyviou@evcgroup.com; tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-to-report-third-quarter-2023-results-on-november-9-2023-301980592.html
SOURCE BIOLASE, Inc.